Related references
Note: Only part of the references are listed.Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs
Natarajan Aravindan et al.
CELL BIOLOGY AND TOXICOLOGY (2021)
The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma
Hsiu-Hao Chang et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes
Qin Liang et al.
SCIENTIFIC REPORTS (2020)
De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
Dinesh Babu Somasundaram et al.
SCIENTIFIC REPORTS (2019)
ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer
Amanda B. Pilling et al.
Oncotarget (2018)
ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor
Ji Won Lee et al.
CANCER RESEARCH AND TREATMENT (2018)
Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling
Marco Kramer et al.
JOURNAL OF NEUROSCIENCE (2016)
Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis
Angela Bellini et al.
CLINICAL CANCER RESEARCH (2015)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
ALK amplification and protein expression predict inferior prognosis in neuroblastomas
Miao Wang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Current and Future Strategies for Relapsed Neuroblastoma: Challenges on the Road to Precision Therapy
Daniel A. Morgenstern et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma et al.
PEDIATRIC BLOOD & CANCER (2013)
Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
Candy Kumps et al.
PLOS ONE (2013)
ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
Md. Kamrul Hasan et al.
SCIENTIFIC REPORTS (2013)
Factors associated with treatment delay among tuberculosis patients referred from a tertiary hospital in Dhaka City: a cross-sectional study
W. Htike et al.
PUBLIC HEALTH ACTION (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
High Anaplastic Lymphoma Kinase Immunohistochemical Staining in Neuroblastoma and Ganglioneuroblastoma Is an Independent Predictor of Poor Outcome
Floor A. M. Duijkers et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Teeara Berry et al.
CANCER CELL (2012)
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
Shizhen Zhu et al.
CANCER CELL (2012)
New Strategies in Refractory and Recurrent Neuroblastoma: Translational Opportunities to Impact Patient Outcome
Kristina A. Cole et al.
CLINICAL CANCER RESEARCH (2012)
Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
C. Schonerr et al.
ONCOGENE (2012)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Linda J. Valentijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
Johannes H. Schulte et al.
CLINICAL CANCER RESEARCH (2011)
Genome-Wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma
Marcella Devoto et al.
HUMAN HEREDITY (2011)
Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
Wendy B. London et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment and Outcomes of Patients With Relapsed, High-Risk Neuroblastoma: Results of German Trials
Thorsten Simon et al.
PEDIATRIC BLOOD & CANCER (2011)
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain
Christian C. Lee et al.
BIOCHEMICAL JOURNAL (2010)
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
Malcolm A. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
Lorena Passoni et al.
CANCER RESEARCH (2009)
Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry
Alberto Garaventa et al.
EUROPEAN JOURNAL OF CANCER (2009)
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
Disease control intervals in high-risk neuroblastoma
Victor M. Santana et al.
CANCER (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Factors influencing survival in children with recurrent neuroblastoma
L Lau et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
WG Dirks et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Expression of the ALK tyrosine kinase gene in neuroblastoma
L Lamant et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
